Analysis of microRNA expression in CD133 positive cancer stem-like cells of human osteosarcoma cell line MG-63

被引:6
|
作者
Shu, Xiong [1 ]
Liu, Weifeng [2 ]
Liu, Huiqi [3 ]
Qi, Hui [1 ]
Wu, Chengai [1 ]
Ran, Yu-Liang [4 ]
机构
[1] Beijing JiShuiTan Hosp, Beijing Res Inst Traumatol & Orthopaed, Beijing, Peoples R China
[2] Peking Univ, Beijing Jishuitan Hosp, Dept Orthopaed Oncol Surg, Beijing, Peoples R China
[3] Qinghai Univ, Med Coll, Xining, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Mol Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
来源
PEERJ | 2021年 / 9卷
基金
中国国家自然科学基金;
关键词
Osteosarcoma; Cancer stem cells; CD133; microRNA; miR-4284; PROLIFERATION; CHEMORESISTANCE; PROGRESSION; BIOMARKER; SERVES; GROWTH; MODEL; MIRNA;
D O I
10.7717/peerj.12115
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Osteosarcoma (OS) is a primary malignant tumor of bone occurring in young adults. OS stem cells (OSCs) play an important role in the occurrence, growth, metastasis, drug resistance and recurrence of OS. CD133 is an integral membrane glycoprotein, which has been identified as an OSC marker. However, the mechanisms of metastasis, chemoresistance, and progression in CD133(+) OSCs need to be further explored. In this study, we aim to explore differences in miRNA levels between CD133(+) and CD133(-) cells from the MG-63 cell line. We found 20 differentially expressed miRNAs (DEmiRNAs) (16 upregulated and 4 downregulated) in CD133(+) cells compared with CD133(-) cells. Hsa-miR-4485-3p, hsa-miR-4284 and hsa-miR-3656 were the top three upregulated DEmiRNAs, while hsa-miR-487b-3p, hsa-miR-493-5p and hsa-miR-431-5p were the top three downregulated DEmiRNAs. In addition, RT-PCR analysis confirmed that the expression levels of hsa-miR-4284, hsa-miR-4485-3p and hsa-miR-3656 were significantly increased, while the expression levels of hsa-miR-487b-3p, hsa-miR-493-5p, and hsa-miR-431-5p were significantly decreased in CD133(+) cells compared with CD133(-) cells. Moreover, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis revealed that predicted or validated target genes for all 20 DEmiRNAs or the selected 6 DEmiRNAs participated in the "PI3K-Akt signaling pathway," "Wnt signaling pathway," "Rap1 signaling pathway," "Cell cycle" and "MAPK signaling pathway". Among the selected six DEmiRNAs, miR-4284 was especially interesting. MiR-4284 knockdown significantly reduced the sphere forming capacity of CD133(+) OS cells. The number of invasive CD133(+) OS cells was markedly decreased after miR-4284 knockdown. In addition, miR-4284 knockdown increased the p-beta-catenin levels in CD133(+) OS cells. In conclusion, RNA-seq analysis revealed DEmiRNAs between CD133(+) and CD133(-) cells. MiRNAs might play significant roles in the function of OSCs and could serve as targets for OS treatment. MiR-4284 prompted the self-renewal and invasion of OSCs. The function of miR-4284 might be associated with the Wnt signaling pathway.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts
    Hu, Hao
    Zhang, Yi
    Cai, Xian-Hua
    Huang, Ji-Feng
    Cai, Lin
    [J]. ONCOLOGY LETTERS, 2012, 4 (05) : 1037 - 1042
  • [2] Cd133(+) stem cells in a cell line of human osteosarcoma (SAOS2)
    Tirino, V.
    Desiderio, V.
    Graziano, A.
    d'Aquino, R.
    De Francesco, F.
    D'Anna, M.
    Pirozzi, G.
    [J]. CYTOMETRY PART A, 2008, 73A (01) : 108 - 108
  • [3] Potential Role of CD133 Expression in the Susceptibility of Human Liver Cancer Stem-Like Cells to TRAIL
    Lee, Su-Hoon
    Hyun, Suh-Kyung
    Kim, Hak-Bong
    Kang, Chi-Dug
    Kim, Sun-Hee
    [J]. ONCOLOGY RESEARCH, 2016, 24 (06) : 495 - 509
  • [4] MMP-1 Over-expression Promotes Malignancy and Stem-Like Properties of Human Osteosarcoma MG-63 Cells In Vitro
    Man-li Tang
    Xiang-jun Bai
    Yong Li
    Xiao-jing Dai
    Fan Yang
    [J]. Current Medical Science, 2018, 38 : 809 - 817
  • [5] MMP-1 Over-expression Promotes Malignancy and Stem-Like Properties of Human Osteosarcoma MG-63 Cells In Vitro
    Tang, Man-li
    Bai, Xiang-jun
    Li, Yong
    Dai, Xiao-jing
    Yang, Fan
    [J]. CURRENT MEDICAL SCIENCE, 2018, 38 (05) : 809 - 817
  • [6] CD133 Positive Embryonal Rhabdomyosarcoma Stem-Like Cell Population Is Enriched in Rhabdospheres
    Walter, Dagmar
    Satheesha, Sampoorna
    Albrecht, Patrick
    Bornhauser, Beat C.
    D'Alessandro, Valentina
    Oesch, Susanne M.
    Rehrauer, Hubert
    Leuschner, Ivo
    Koscielniak, Ewa
    Gengler, Carole
    Moch, Holger
    Bernasconi, Michele
    Niggli, Felix K.
    Schaefer, Beat W.
    [J]. PLOS ONE, 2011, 6 (05):
  • [7] Human renal stem-like cells: CD133 is real kidney stem cell marker for distinction between normal and cancer stem cell
    Abbasi, Mohammad R.
    Heidari-Keshel, Saeed
    Behrouzi, Gholamreza
    Rozafzoon, Reza
    Zahed, Reza
    Aghazadeh, Sara
    Aghajanpour, Leilia
    Omidi, Roghaye
    Bashtar, Maryam
    Zaredar, Nafiseh
    Khoshzaban, Ahad
    [J]. MINERVA BIOTECNOLOGICA, 2017, 29 (02) : 101 - 106
  • [8] Isolation of stem-like cells from human MG-63 osteosarcoma cells using limiting dilution in combination with vincristine selection
    Lou, Nan
    Wang, Yan
    Sun, Dahui
    Zhao, Jianwu
    Wang, Yang
    Gao, Zhongli
    [J]. INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2010, 47 (06): : 340 - 347
  • [9] CD133 Positive Cancer Stem-Like Cells Are Induced Through Notch Signaling Pathway in Poorly Differentiated Human Gastric Cancer
    Konishi, Hidetomo
    Asano, Naoki
    Imatani, Akira
    Kondo, Yutaka
    Koike, Tomoyuki
    Iijima, Katsunori
    Ohara, Shuichi
    Shimosegawa, Tooru
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A460 - A460
  • [10] Notch pathway blockade inhibits glioblastoma growth by depleting CD133 positive stem-like cancer cells
    Fan, Xing
    Khaki, Leila
    Coonfield, Michael
    Koh, Cheryl
    Zhang, Jiangyang
    Li, Yue-Ming
    DiMeco, Francesco
    Vescovi, Angelo
    Eberhart, Charles
    [J]. CANCER RESEARCH, 2008, 68 (09)